📅 On April 24 at 9:30 AM in Katowice, as part of the 17th European Economic Congress, a discussion panel titled “Presidency in Health at Its Final Stage” will take place
Under the auspices of the Polish Presidency of the Council of the EU, on April 10–11, the Ministry of Health, in cooperation with the European Economic and Social Committee and the Medical University of Warsaw, organized the conference “Towards an EU Action Plan on Rare Diseases”
📢 We cordially invite you to register for a groundbreaking conference on rare diseases! 🇪🇺 🇵🇱 On April 10, 2025, at 9:00, the European Economic and Social Committee (EESC), the Ministry of Health of the Republic of Poland, and the Medical University of Warsaw (WUM) are organizing a conference “Towards an EU Action Plan on Rare Diseases” as part of the Polish Presidency of the Council of the European Union.
HACK4HEALTH 🏥💡: The health of Polish citizens 🇵🇱 is not solely the responsibility of the Ministry of Health, the National Health Fund (NFZ), or other healthcare institutions. All public institutions should consider health aspects in their actions and planning
The European Health Data Space (EHDS) could be crucial for patients with rare diseases. Some countries are unable to support their patients because they lack the necessary resources, technology, or infrastructure
In my opinion, it is crucial for Europe to move forward together. This is not just about rare diseases 🧬, cancer 🎗, neurological disorders 🧠, rheumatological conditions, or cardiovascular diseases ❤️, but about health in general 🌍
🛑”HIV infection prevention starts with early detection. 🔬 Early detection enables quick treatment 💊, and treatment ensures that a person living with HIV is no longer infectious” 🏥✅
“Equalizing Opportunities: Can Polish Patients Join the European Leaders, and Can Bladder Cancer Become One of the Optimally Treated Cancers?” – a debate organized on February 26 by the Institute for Social Affairs Development and the Medical Center of the Medical University of Warsaw. The discussion featured leading experts, as well as representatives of public institutions and patient organizations.